‌$Novavax(NVAX)$‌Novavax has shipped its first shipment to US!https://www.mea.gov.in/vaccine-supply.htm

‌$Novavax(NVAX)$‌Novavax Statement on European Medicines Agency Nuvaxovid™ Label Update Related to Allergic ReactionJul 14, 2022 Today, the European Medicines Agency (EMA) updated the label for our COVID-19 vaccine (NVX-CoV2373) to include the risk of severe allergic reactions. This update is a warning commonly included for commercially available vaccines, including COVID-19 vaccines. Novavax’ clinical development program reported no severe allergic reactions and therefore, this risk was not listed in the initial product label. With broader deployment of doses, we have received reports of two cases of anaphylaxis (allergic reaction) that met a probable/definite case definition. Because anaphylaxis can occur with all vaccines and based on these cases

$Tesla Motors(TSLA)$Was hoping that the fortune tellers are right... where is my $400???? Maybe after share split...😂😂

‌$Novavax(NVAX)$‌India's SII to halve output of AstraZeneca vaccine (not novavax)About 200 million doses of COVID-19 vaccine are gathering dust in warehouses of the world’s largest vaccine manufacturer as global demand ebbs. Serum Institute of India (SII) stopped making new COVID-19 vaccine doses in December, CEO Adar Poonawalla said at the India Economic Conclave, as quoted by Bloomberg. The company currently sits on a stockpile of 200 million doses, he said.Sourceshttps://www.fiercepharma.com/pharma/200m-unused-doses-astrazenecas-covid-vaccine-partner-serum-institute-halts-production#:~:text=With%20200M%20unused%20doses%2C%20AstraZeneca's%20COVID%20vaccine%20partner%20Serum%20Institute%20halts%20production,-By%20Angus%20Liu&text=About%2020

$Tesla Motors(TSLA)$Why did it go up so much??? I was hoping to buy 100 shares at $400each! 😂😂😂Fortunately I bought some at shares yesterdayand enjoyed the rally. I am pretty sure some fortune teller would come and say be careful or the rally is going to collapse and $400 will come soon. I have hearing $400 is coming soon for a very long time... 

‌$Novavax(NVAX)$‌New data on COVID-19 Influenza combination vaccine and seasonal influenza vaccine to be presented at World Vaccine CongressNovavax will provide a first look at data from its COVID-19 influenza combination vaccine and seasonal influenza vaccine trials, at the World Vaccine Congress (WVC) in Washington, DC, April 18 - 21, 2022. In addition, the latest data on its protein-based COVID-19 vaccine candidate, NVX-CoV2373, will be presented at both WVC and the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in in Lisbon, Portugal, April 23 - 26, 2022. Data from eight abstracts and presentations, including four oral presentations, will be presented across the two congresses.NanoFlu identifies a recombinant h

‌$Novavax(NVAX)$‌Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India1. First authorization of Novavax' COVID-19 vaccine in adolescent population received 2. Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorized for adolescents ≥12 to <18 in India3. Authorization highlights immunogenicity and reassuring safety profile of Covovax in Phase 2/3 study of Indian adolescents aged ≥12 to <18 and data from an ongoing Phase 3 pediatric expansion trial of NVX-CoV2373 in adolescents aged ≥12 to <18 in the U.S.Extracted from:https://ir.novavax.com/2022-03-22-Novavax-and-

‌$Novavax(NVAX)$‌3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall StreetNovavax: Implied upside of 257% The first COVID-19 play that offers drool-worthy upside, at least according to one Wall Street analyst, is biotech stock Novavax ( NVAX -13.36% ). Despite a $50 price-target reduction in February, B. Riley analyst Mayank Mamtani still believes Novavax can reach $265 a share. This represents a cool 257% upside from where shares ended last week. Mamtani's aggressive price target is based on a few factors. For instance, he believes that concerns over Novavax's near-term manufacturing struggles are overblown. Mamtani explained months ago that Novavax was nearing its monthly manufacturing target of around 150 million doses, and wo

‌$Novavax(NVAX)$FDA 'slow-walking' Novavax authorizationThe FDA declined to comment on the pending applications, and Novavax has no updates on a potential time for the FDA's advisory committee meeting. Lawrence Gostin, director of the O'Neill Institute for National and Global Health Law at Georgetown University, says the FDA is "slow-walking" Novavax's authorization. "They've got all the data that they need, but I'd say it's also kind of a general irritation with the company," Gostin told Yahoo Finance. That "irritation" stems from earlier issues with manufacturing and other delays, which are now resolved. But in relying on a plant abroad — the Serum Institute of India, the world's largest vaccine maker — Novavax has opened the door for more scrut

‌$Novavax(NVAX)$‌Novavax's Matrix M in Malaria Vaccine Shows Promising ResultsR21* is a protein-based investigational vaccine developed by the University of Oxford, using our Matrix-M™ adjuvant technology.1 This investigational vaccine is specifically designed to help protect against malaria.https://www.economist.com/science-and-technology/2022/09/08/a-new-malaria-vaccine-shows-promising-results

$Novavax(NVAX)$Ha! Nice number! Hope to see 88.88 soon 

In this era, money is power. He is rich beyond imagination, and that gives him knowledge and insight of companies that most people will never have access to.The first point that he investing in a company if and only if you understand it's management and business model. How many people can get the same level of understanding as Buffett?Keep your positions for as long as possible. Yeah, if I am as rich as him, I will invest in a company, delete the broker app and never bother to look at my investment in years to come. 

$Novavax(NVAX)$Moderna recalls thousands of COVID vaccine doses in EuropeApril 8 (Reuters) - Moderna Inc (MRNA.O) said on Friday it was recalling 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi (ROVI.MC) after a vial was found contaminated by a foreign body.No safety issues have been identified, Moderna said about the lots that were distributed in Norway, Poland, Portugal, Spain and Sweden in January.https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-recalls-thousands-covid-vaccine-doses-2022-04-08/

$Novavax(NVAX)$Truth for the delays?Novavax acknowledged to Reuters that it had only delivered 10 million doses, and said that shipments had been delayed by regulatory processes. It said that in some cases, doses are sitting in distribution centers, ready to be sent out.https://www.barrons.com/amp/articles/novavax-stock-tumbles-on-report-that-vaccine-deliveries-are-lagging-51644334599